Martina Wiedau

Martina Wiedau, M.D., is a Professor in the Department of Clinical Health Sciences at the David Geffen School of Medicine, University of California, Los Angeles. Her primary affiliation is the Neuroscience Research Building, where she conducts research focused on neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS).

Dr. Wiedau's research encompasses:

• ALS Pathogenesis: Genetic mechanisms (e.g., SOD1 mutations), protein aggregation, and neuroinflammation.
• Therapeutic Development: Clinical trials for drugs like edaravone, tofersen, and mexiletine; alternative treatments (e.g., psilocybin, ashwagandha).
• Palliative Care: Optimizing symptom management (e.g., sialorrhea, muscle cramps) and integrating universal palliative referrals in multidisciplinary clinics.

Her recent publications (2020–2025) demonstrate a strong emphasis on translating basic research into clinical applications, with recurring themes in genetic association studies, antioxidant therapies, and palliative care frameworks for ALS patients.

No awards, grants, or student advisees are documented in the provided information.